News Archives - ARC Oxford

Ultromics granted FDA Breakthrough Device Designation

Biotech company Oxford BioDynamics awarded $963,000

OMass Therapeutics makes move to ARC Oxford as it announces new phase of growth

ARC Oxford becomes latest member of Advanced Oxford

ARC gets lab space down to a science

Oxbotica partnership to take autonomous deliveries to Europe

Scientists create new blood test for prostate cancer that is 94% accurate

Perspectum Completes $36 Million First Close of Series C Funding

Accession Therapeutics raises funding

Growing tomorrow’s innovators

Welcoming ARC Oxford

Compelling long COVID research from ARC Oxford member, Perspectum diagnostics

you've seen 48 of 49 News

1
2
3
4
5